What Osseointegration Group of Australia does

Osseointegration Group of Australia is a Sydney-headquartered clinical and medical device company founded in 2010 by Professor Dr Munjed Al Muderis, specializing in osseointegration surgery for amputees. The group's flagship offering is the OPL (Osseointegrated Prosthetic Limb) implant system, manufactured under OEM arrangement with Italian partner Permedica, available in 800+ size configurations to fit a wide spectrum of residual limb anatomies. The clinical procedure is delivered under the proprietary OGAAP-2 single-stage surgical protocol, paired with a structured three-phase rehabilitation program, which the company positions as a differentiator versus traditional two-stage approaches. The OPL implant is paired with externally mounted prosthetic components that patients use as their everyday limb replacement.

The business monetizes through per-patient surgical fees, implant sales (via the Permedica OEM channel), and ongoing rehabilitation and prosthetic component services. The company has treated more than 1,500 patients cumulatively across its clinical network, anchored by a Sydney headquarters and Abu Dhabi clinic, with additional Warsaw operations through the Paley European Institute partnership. Referral and clinical partnerships with Relimb (UK), American Mission Hospital (Bahrain), and Permedica (Italy) extend reach into Europe and the Gulf without requiring fully owned clinics in each market. The OPL device is not currently approved in the United States, which materially constrains the addressable market relative to the global amputee population, and the company supplements clinical delivery with international prosthetist training and virtual education programs to credential external clinicians on the OPL platform.

The company is privately held and founder-owned, with no public revenue or funding disclosures. Strategic intent is clearly oriented toward international expansion through a combination of owned clinics (Sydney, Abu Dhabi), partner clinics (Warsaw), and referral/training networks in additional markets, alongside continued implant portfolio development such as the OPL Type D range launched in February 2023.

Name

Osseointegration Group of Australia

Legal name

The Osseointegration Group

Website

https://osseointegration.org

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

Osseointegration Group of Australia is a Sydney-based clinical and medical device company founded by Professor Dr Munjed Al Muderis that performs bone-anchored prosthetic limb (OPL) surgery for amputees globally through owned clinics and partner networks.

Ownership category

akta.pro rank

Product category

Osseointegration Prosthetic Surgery

NAICS

Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134), Offices of Physical, Occupational and Speech Therapists, and Audiologists (621340)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841), Services-Health Services (8000)

akta.pro primary industry

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

akta.pro secondary industries

Orthopedic Surgery (Operative Orthopedics) (HLAKALAC), Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB), Hand & Upper Extremity (HLAKALAF)

Keywords

• Osseointegration surgery
• Bone-anchored prosthetics
• Limb reconstruction
• Prosthetic implant system
• Amputation rehabilitation

Headquarters

HQ city

Sydney

HQ country

Australia

HQ region

Oceania

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Surgical Procedures: Primary revenue from osseointegration surgical procedures, pre-operative assessments, and post-operative rehabilitation services. Individual treatment plans with costs varying based on amputation type, complexity, and additional procedures required.
2. OPL Implant System: Osseointegrated Prosthetic Limb (OPL) implants manufactured by Permedica. Compatible with commercially available prosthetic components. System available in over 800 size configurations.

Pricing tiers

Go-to-market motion2 records

Distribution channels7 records

Marketing channels9 records

Core offering

The Osseointegration Group of Australia performs osseointegration surgery to implant the Osseointegrated Prosthetic Limb (OPL) — a titanium alloy intramedullary implant with ceramic coating and plasma-sprayed titanium stem — into the residual bone of amputees, providing bone-anchored prosthetic attachment that eliminates traditional socket prostheses. Services span single-stage surgical procedures (OGAAP-2 protocol), a structured three-phase rehabilitation program, prosthetist training, accredited surgical fellowships, and distribution of the OPL implant system through wholly-owned Osseointegration International across clinics in Australia, UAE, Poland, and partner networks in the UK, Italy, and Bahrain.

Product overview

Osseointegration Group of Australia offers a unified medical service centered on the Osseointegrated Prosthetic Limb (OPL) implant system — a bone-anchored prosthetic solution for amputees. The core offering consists of single-stage osseointegration surgery to implant the OPL, followed by a structured three-phase rehabilitation program. The portfolio is complemented by professional training for prosthetists and accredited surgical fellowships for orthopaedic surgeons. The OPL system is manufactured by Permedica and is available in over 800 size configurations, with a recent Type D range extension adding 66 new sizes and hybrid 3D-printed custom implant options.

Differentiator

Problem solved

Functional benefit

Products and services

• Osseointegrated Prosthetic Limb (OPL) The OPL is a bone-anchored prosthetic implant system that provides direct skeletal attachment for amputees, eliminating the need for traditional socket prostheses. It features a titanium alloy (Ti6Al4V) intramedullary implant with an ultra-smooth ceramic coating at the transcutaneous interface and plasma-sprayed pure titanium along the stem, available in over 800 size configurations with a rapid connector system for ~5 second prosthesis attachment.
• Single-Stage Osseointegration Surgery (OGAAP-2) A surgical procedure where the OPL implant is inserted into the residual bone in a single operation under Prof Al Muderis's OGAAP-2 protocol, enabling faster rehabilitation, reduced osteomyelitis incidence (0% vs 10% in two-stage), and significantly lower implant failure rates. Indicated for upper and lower limb amputees (transfemoral, transtibial, transhumeral, transradial, digital, shoulder, hip) and selected CRPS patients.
• Osseointegration Rehabilitation Program A structured three-phase rehabilitation program following osseointegration surgery, progressing from initial weight-bearing through advanced gait training and mobility optimization. Provided as part of the integrated treatment pathway at the Limb Reconstruction Centre in Sydney and partner clinics.
• Prosthetist Training Program Continuing education program for prosthetists covering osseointegration techniques, alignment and fitting considerations, connector systems, and troubleshooting for osseointegrated patients. Delivered virtually and on-site at the Limb Reconstruction Centre.
• Surgical Fellowship Program Accredited fellowship opportunities for orthopaedic surgeons to train in osseointegration techniques under Prof Dr Munjed Al Muderis, including hands-on surgical experience, research opportunities, and multidisciplinary learning at the world's largest osseointegration centre.

Quantifiable outcome

• 82% of lower limb amputees develop socket-related complications; up to 57% eventually abandon socket prostheses due to pain and soft tissue problems
• +6 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• American Mission Hospital (AMH)coreStrategic or Co-development Partner · 1 January 2025Partnership with prestigious not-for-profit American Mission Hospital in Manama, Bahrain to establish 'Al Muderis and Associates Limb Reconstruction and Deformity Correction Institute' - regional centre of excellence for osseointegration and limb reconstruction.
• Atlas Global AidminorGTM or Marketing Partner · 1 January 2024US-based charity organization that facilitated evacuation and treatment of Ukrainian soldier Viktor Bogoyavlensky. CEO Jack Frye's brother had previous osseointegration with Prof Al Muderis.
• RelimbcoreChannel Partner/ Reseller/ Distributor · 1 January 2018UK's first civilian treatment pathway for osseointegration and TMR, founded by Mr. Norbert Kang and Mr. Alexander Woollard, plastic surgeons from North London's Royal Free Hospital.
• Permedica OrthopaedicscoreOEM/ Whitelabel/ Licensing PartnerItalian orthopaedic manufacturer that produces the OPL (Osseointegrated Prosthetic Limb) implant system designed by Prof Al Muderis. Permedica also developed a specialized business unit for 3D printed custom implants. Partnership enables hybrid approach of off-the-shelf and custom solutions.
• Paley European Institute (PEI)coreStrategic or Co-development PartnerWarsaw-based orthopaedic institute providing world-class osseointegration and limb reconstruction care in Europe. Prof Al Muderis travels regularly to consult and operate. PEI surgeons trained directly by Prof Al Muderis.
• Centro Medico La SaletteminorChannel Partner/ Reseller/ DistributorItalian rehabilitation clinic specializing in post-operative and post-traumatic rehabilitation. Dr. Tiziano Villa, Italian osseointegration expert, leads the practice.
• Dorset OrthopaedicsminorChannel Partner/ Reseller/ DistributorUK-based interdisciplinary team of prosthetists, orthotists, and physiotherapists providing comprehensive prosthetic care. Partners with Relimb for UK osseointegration patients.
• Macquarie University HospitalcoreStrategic or Co-development PartnerHost institution for Osseointegration Group Clinics at the Limb Reconstruction Centre. Provides surgical facilities and academic affiliation through Macquarie University.

Scale indicators6 records

Recent moves9 records

Expansion highlights6 records

Broad incumbents

• Ossur: Major global prosthetics and orthotics manufacturer offering sophisticated socket-based limbs and bionic solutions; competes functionally for amputee patients and also operates the Rheo Knee and other advanced components that pair with osseointegration implants.
• Zimmer Biomet: Global orthopedic medical device leader with extensive orthopedic reconstruction and implant portfolio; competes with OPL for orthopedic reconstruction and could become a bone-anchored prosthetic competitor via its scale and R&D.
• Enovis (DJO Global): Medical device company with deep orthopedic, reconstructive, and rehabilitation franchises including bracing and orthopedic implants; competes with OPL indirectly as a broader orthopedic solutions provider and could expand into bone-anchored implants.
• Stryker: Large multi-specialty orthopedic medical device company with a broad orthopedic, trauma, and surgical implant portfolio; competes with OPL through orthopedic implants and digital surgery, and has acquired Stanmore Implants to access limb salvage and tumor prostheses.
• Ottobock: Global market leader in prosthetics and orthotics with a wide portfolio of socket-based prosthetic components and emerging bone-anchored solutions; competes with OPL for amputees via a much broader product range and established reimbursement relationships.
• Smith & Nephew: Diversified medical device company with orthopedic, sports medicine, and reconstruction franchises; comparable to the Osseointegration Group as a major orthopedic device and surgical solution provider serving hospitals and surgeons globally.
• Hanger Clinic: Large US-based provider of orthotic and prosthetic patient care services; competes for the same amputee patients via traditional socket-based prostheses and is a likely candidate to partner with or compete against the Osseointegration Group in the US market.

Emerging players

• College Park Industries: Specialty prosthetic component manufacturer focused on lower-limb prosthetic feet and componentry; competes with OPL in the prosthetic limb space, particularly in the US, and could play a role in the supply chain for osseointegrated prosthetic attachments.

Direct peers

• Integrum: Sweden-based company developing the OPRA Osseointegration Implant System, the most direct global competitor to OPL; targets the same amputee population and has obtained FDA breakthrough designation for its system, putting it ahead of OPL in the US market.

Others

• Permedica Orthopaedics: Italian orthopedic manufacturer that is the OEM partner producing the OPL implant system for the Osseointegration Group; adjacent peer as it is also a broader orthopedic device company with its own product line, and a strategic dependency for the Group.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@Osseointegration
• Facebookfacebook.com/OsseointegrationGroup
• LinkedInlinkedin.com/company/osseointegration-international
• Instagraminstagram.com/osseointegrationau
• Xx.com/osseoint

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Osseointegration Group of Australia